Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Hypersensitivity pneumonitis HP is a lung condition caused by an allergic reaction to inhaled organic substances, often leading to lung fibrosis and chronic respiratory failure. This research evaluates the role of the indoor environment medical advisor CMEI in identifying the antigens responsible for fibrosing HP. Correctly identifying these antigens is crucial to managing the disease, especially since many cases have unknown triggers and current treatments have limited effects on disease progression. Participants diagnosed with fibrosing HP will complete a medical self-exposure questionnaire, followed by a home visit from the CMEI. The visit includes an environmental audit with a visual inspection, microbiological swabs, and placement of electrostatic dust sensors for four weeks to collect antigen data. Serum precipitin tests will be performed based on identified antigens. Follow-up includes a 6-month phone evaluation and a 12-month home visit to assess the removal of identified antigens. Throughout the study, participants will undergo clinical, functional, and radiological assessments at diagnosis, 6 months, and 12 months, including chest CT scans. The study measures how effectively the CMEI identifies antigens, the usefulness of dust sensors, and the impact of antigen avoidance on clinical outcomes. The total participation lasts at least 12 months, with ongoing monitoring of antigen exposure and patient health.